Plant ID: NPO12265
Plant Latin Name: Aquilaria agallochum
Taxonomy Genus: Aquilaria
Taxonomy Family: Thymelaeaceae
NCBI TaxonomyDB:
1472648
Plant-of-the-World-Online:
n.a.
India
FAAH; TDP1; TERT; | |
PPARA; PPARD; PPARG; | |
TLR2; | |
FABP3; FABP2; FABP4; FABP5; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | FAAH | Anandamide amidohydrolase | O00519 | CHEMBL2243 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | TERT | Telomerase reverse transcriptase | O14746 | CHEMBL2916 |
Nuclear hormone receptor subfamily 1 group C | PPARA | Peroxisome proliferator-activated receptor alpha | Q07869 | CHEMBL239 |
Nuclear hormone receptor subfamily 1 group C | PPARD | Peroxisome proliferator-activated receptor delta | Q03181 | CHEMBL3979 |
Nuclear hormone receptor subfamily 1 group C | PPARG | Peroxisome proliferator-activated receptor gamma | P37231 | CHEMBL235 |
Toll-like and Il-1 receptors | TLR2 | Toll-like receptor 2 | O60603 | CHEMBL4163 |
Unclassified | FABP3 | Fatty acid binding protein muscle | P05413 | CHEMBL3344 |
Unclassified | FABP2 | Fatty acid binding protein intestinal | P12104 | CHEMBL4879 |
Unclassified | FABP4 | Fatty acid binding protein adipocyte | P15090 | CHEMBL2083 |
Unclassified | FABP5 | Fatty acid binding protein epidermal | Q01469 | CHEMBL3674 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0019433; triglyceride catabolic process | 2.165E-09 | 5.238E-06 | FABP2, FABP3, FABP4, FABP5 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 6.054E-09 | 9.416E-06 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 6.642E-08 | 7.232E-05 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 1.289E-07 | 1.220E-04 | FABP3, PPARA, PPARD, PPARG |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 5.322E-07 | 3.863E-04 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 1.463E-06 | 8.609E-04 | CYP2D6, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0032868; response to insulin | 2.431E-06 | 1.291E-03 | FABP3, PPARA, PPARG, TLR2 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 2.924E-06 | 1.481E-03 | CYP1A2, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 4.224E-06 | 2.044E-03 | CYP1A2, CYP2D6, CYP3A4 |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 4.872E-06 | 2.306E-03 | PPARA, PPARG |
MF | GO:0140110; transcription regulator activity | GO:0004879; nuclear receptor activity | 5.475E-06 | 2.442E-03 | PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 7.305E-06 | 3.022E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 7.305E-06 | 3.022E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 7.356E-06 | 3.022E-03 | CYP1A2, CYP2D6, FAAH |
MF | GO:0005488; binding | GO:0050543; icosatetraenoic acid binding | 7.305E-06 | 3.022E-03 | FABP3, PPARG |
MF | GO:0060089; molecular transducer activity | GO:0003707; steroid hormone receptor activity | 9.620E-06 | 3.809E-03 | PPARA, PPARD, PPARG |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 2.410E-05 | 8.745E-03 | FABP3, PPARG, TLR2 |
BP | GO:0008152; metabolic process | GO:1902894; negative regulation of pri-miRNA transcription from RNA polymerase II promoter | 2.673E-05 | 9.542E-03 | PPARA, PPARD |
BP | GO:0050896; response to stimulus | GO:0001666; response to hypoxia | 2.844E-05 | 9.830E-03 | PPARA, PPARD, TERT, TLR2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09150 Organismal Systems | 09152 Endocrine system | hsa03320 | PPAR signaling pathway | 1.432E-14 | 6.874E-13 | FABP2, FABP3, FABP4, FABP5, PPARG, PPARA, PPARD |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.392E-05 | 2.640E-04 | CYP2D6, CYP1A2, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.650E-05 | 2.640E-04 | CYP2D6, CYP1A2, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.828E-04 | 2.193E-03 | CYP1A2, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 7.355E-04 | 7.061E-03 | CYP1A2, CYP3A4 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 9.229E-04 | 7.383E-03 | CYP1A2, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.464E-03 | 1.004E-02 | CYP1A2, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05216 | Thyroid cancer | 2.012E-02 | 1.073E-01 | PPARG |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 3.783E-02 | 1.106E-01 | TLR2 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 3.495E-03 | 2.097E-02 | CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Anxiety disorder | F32, F40-F42 | CYP3A4; |